Corindus Highlights Interventional Robotic Navigation


February 27, 2013
Corindus CorPath 200

February 26, 2013 — Corindus Vascular Robotics will showcase its U.S. Food and Drug Administration (FDA)-cleared CorPath 200 Vascular Robotic-Assisted System at the American College of Cardiology 2013 meeting, March 9-11. The company will be conducting live demos of the system at booth N6157 throughout the conference. 

CorPath Angioplasty is the first and only robotic program for interventional cardiologists and a major step forward in the cath lab, enhancing a procedure that is conducted almost 1 million times each year in the United States.  
The system offers precise device control, sub-millimeter measuring capability, discrete 1 mm device movements, 95 percent reduction in physician radiation and eliminates the need to wear lead aprons during a procedure while sitting at the CorPath cockpit. 
For more information:


The content of this field is kept private and will not be shown publicly.
Type the characters you see in this picture. (verify using audio)
Type the characters you see in the picture above; if you can't read them, submit the form and a new image will be generated. Not case sensitive.